Guillain-Barré syndrome in COVID-19 vaccinated patients: There is a lot to uncover
Clin Neurol Neurosurg
.
2024 Dec 24:249:108712.
doi: 10.1016/j.clineuro.2024.108712.
Online ahead of print.
Authors
Mohammad T Abuawwad
1
,
Mohammad J J Taha
1
,
Ahmad J Taha
1
,
Yasmeena Abdelall Kozaa
2
,
Obaida Falah
1
,
Ibrahim T Abuawwad
1
,
Elsayed Mohamed Hammad
3
,
Ayman A Mahmoud
4
,
Mohammad Aladawi
5
,
Hashem Abu Serhan
6
Affiliations
1
Department of Clinical Medicine, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.
2
Mansoura Manchester Programme for Medical Education, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
3
Department of Clinical Medicine, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
4
Rheumatology and Clinical Immunology Unit, Internal Medicine Department, Faculty of Medicine, Cairo University, Egypt.
5
Department of Neurological Sciences, University of Nebraska Medical Center, NE, USA.
6
Department of Ophthalmology, Hamad Medical Corporations, Doha, Qatar. Electronic address:
[email protected]
.
PMID:
39731974
DOI:
10.1016/j.clineuro.2024.108712
No abstract available
Keywords:
Autoimmunity; COVID-19; Guillain-Barré Syndrome; SARS-CoV-2; Vaccines.
Publication types
Letter